Reperfusion in acute myocardial infarction: Effect of timing and modulating factors in experimental models

https://doi.org/10.1016/0002-9149(93)90102-IGet rights and content

Abstract

Timely reperfusion of ischemic myocardium in experimental animals halts the advancing transmural “wavefront” of ischemic cell death and thereby limits myocardial infarct size by limiting its transmural extent. The time window of opportunity for such salvage in most experimental models of regional ischemia is the first 3 hours. The number of myocytes that can be salvaged by reperfusion decreases exponentially during this period, such that at 3 hours, reperfusion limits infarct size by only about 10%. The rate of lethal ischemic cell injury and therefore the amount of myocardium that can be salvaged by reperfusion after a particular duration of ischemia is dependent both on the degree of blood flow deficit and the rate of ischemic metabolism. In experimental animal models, several interventions, including hypothermia, calcium antagonists, and “ischemic preconditioning,” have been shown to reduce the rate of ischemic metabolism and to limit myocardial infarct size when assessed after a defined period of ischemia and reperfuslon. Hypothetically, interventions that could prevent additional myocyte necrosis caused by some deleterious aspects of reperfusion (“lethal reperfusion injury”) also could serve as valuable adjunctive therapy. However, studies of therapies designed to prevent lethal reperfusion injury have produced conflicting results. Thus, the concept that lethal reperfusion injury occurs remains controversial. Experimental evidence indicates that reperfusion accelerates both the initial inflammatory response and later process of infarct repair. Late reperfusion of infarcts in dogs, which does not limit myocardial infarct size, appears to accelerate the replacement of necrotic myocardium by scar without altering the size of the final scar.

References (59)

  • KA Reimer et al.

    Animal models for protecting ischemic myocardium (AMPIM): results of the NHLBI cooperative study. Comparison of the unconscious and conscious dog models

    Circ Res

    (1985)
  • H Fujiwara et al.

    Transmural cellular damage and blood flow distribution in early ischemia in pig hearts

    Circ Res

    (1982)
  • M Lavalee et al.

    Regional myocardial blood flow and necrosis in primates following coronary occlusion

    Am J Physiol

    (1984)
  • WFM Fulton

    Arterial anastomoses in the coronary circulation. I. Anatomical features in normal and diseased hearts demonstrated by sterioarteriography

    Scot Med J

    (1963)
  • RB Jennings et al.

    Ischemic tissue injury

    Am J Pathol

    (1975)
  • DS Hess et al.

    Transmural distribution of myocardial blood flow during systole in the awake dog

    Circ Res

    (1976)
  • A L'Abbate et al.

    Opposite transmural gradients of coronary resistance and extravascular pressure in the working dog's heart

    Cardiovasc Res

    (1980)
  • RJ Bache et al.

    Effect of perfusion pressure distal to a coronary stenosis on transmural myocardial blood flow

    Circulation

    (1982)
  • B Wusten et al.

    The distribution of myocardial flow. I. Effects of experimental coronary occlusion

    Bas Res Cardiol

    (1974)
  • RB Jennings et al.

    Effect of reperfusion late in the phase of reversible ischemic injury. Changes in cell volume, electrolytes, metabolites and ultrastructure

    Circ Res

    (1985)
  • RB Jennings et al.

    Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog

    Arch Pathol

    (1960)
  • KA Reimer et al.

    The wavefront phenomenon of ischemic cell death. I. Myocardial infarct size vs. duration of coronary occlusion in dogs

    Circulation

    (1977)
  • KL Baughman et al.

    Effects of coronary artery reperfusion on myocardial infarct size and survival in conscious dogs

    Circulation

    (1981)
  • CM Connelly et al.

    Movement of necrotic wavefront after coronary artery occlusion in rabbit

    Am J Physiol

    (1982)
  • GG Geary et al.

    Quantitative effect of early coronary artery reperfusion in baboons: extent of salvage of the perfusion bed of an occluded artery

    Circulation

    (1982)
  • HH Klein et al.

    Temporal and spatial development of infarcts in porcine hearts

    Basic Res Cardiol

    (1984)
  • RA Kloner et al.

    Studies of experimental coronary artery reperfusion: effects on infarct size, myocardial function, biochemistry, ultrastructure and microvascular damage

    Circulation

    (1983)
  • W Schaper et al.

    Experimental coronary artery occlusion. II. Spatial and temporal evolution of infarcts in the dog heart

    Basic Res Cardiol

    (1979)
  • JT Lee et al.

    Myocardial infarct size and location in relation to the coronary vascular bed at risk in man

    Circulation

    (1981)
  • Cited by (122)

    • Therapeutic Fibrinolysis: How Efficacy and Safety Can Be Improved

      2016, Journal of the American College of Cardiology
    • Relation between door-to-balloon times and mortality after primary percutaneous coronary intervention over time: A retrospective study

      2015, The Lancet
      Citation Excerpt :

      Door-to-balloon (D2B) time predicts survival in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI).1–3 This relation has been thought to be causal, supported by studies in animals4 and observational evidence5,6 indicating that shorter times to reperfusion are linked to decreased myocardial damage and mortality. As a result, clinical guidelines and national quality initiatives in the past decade have focused on shortening D2B times, including the large D2B Alliance sponsored by the American College of Cardiology (ACC) and the Mission:Lifeline Program led by the American Heart Association (AHA).7–9

    View all citing articles on Scopus

    Supported in part by National Institutes of Health grants HL-27416, HL-23138 and HL-17670.

    1

    Present address Vincent J. Richard is Service de Pharmacologie, CHU de Rouen, Hopital de Bois Guillaume, BP100, 76233 Bois Guillaume Cedex, France.

    View full text